Back to Search
Start Over
Comparison of the Efficacy and Safety of Tacrolimus and Low-Dose Corticosteroid with High-Dose Corticosteroid for Minimal Change Nephrotic Syndrome in Adults
- Source :
- J Am Soc Nephrol
- Publication Year :
- 2019
-
Abstract
- BACKGROUND: Tacrolimus is used as a steroid-sparing immunosuppressant in adults with minimal change nephrotic syndrome. However, combined treatment with tacrolimus and low-dose steroid has not been compared with high-dose steroid for induction of clinical remission in a large-scale randomized study. METHODS: In this 24-week open-label noninferiority study, we randomized 144 adults with minimal change nephrotic syndrome to receive 0.05 mg/kg twice-daily tacrolimus plus once-daily 0.5 mg/kg prednisolone, or once-daily 1 mg/kg prednisolone alone, for up to 8 weeks or until achieving complete remission. Two weeks after complete remission, we tapered the steroid to a maintenance dose of 5–7.5 mg/d in both groups until 24 weeks after study drug initiation. The primary end point was complete remission within 8 weeks (urine protein: creatinine ratio 3.0 g/g) after complete remission to within 24 weeks of study drug initiation. RESULTS: Complete remission within 8 weeks occurred in 53 of 67 patients (79.1%) receiving tacrolimus and low-dose steroid and 53 of 69 patients (76.8%) receiving high-dose steroid; this difference demonstrated noninferiority, with an upper confidence limit below the predefined threshold (20%) in both intent-to-treat (11.6%) and per-protocol (17.0%) analyses. Groups did not significantly differ in time until remission. Significantly fewer patients relapsed on maintenance tacrolimus (3–8 ng/ml) plus tapered steroid versus tapered steroid alone (5.7% versus 22.6%, respectively; P=0.01). There were no clinically relevant safety differences. CONCLUSIONS: Combined tacrolimus and low-dose steroid was noninferior to high-dose steroid for complete remission induction in adults with minimal change nephrotic syndrome. Relapse rates were significantly lower with maintenance tacrolimus and steroid compared with steroid alone. No clinically-relevant differences in safety findings were observed.
- Subjects :
- Adult
medicine.medical_specialty
Adolescent
medicine.drug_class
Prednisolone
030232 urology & nephrology
030204 cardiovascular system & hematology
Gastroenterology
Drug Administration Schedule
Tacrolimus
law.invention
Medication Adherence
03 medical and health sciences
chemistry.chemical_compound
Young Adult
0302 clinical medicine
Randomized controlled trial
law
Adrenal Cortex Hormones
Recurrence
Clinical Research
Internal medicine
Republic of Korea
medicine
Humans
Aged
Creatinine
Maintenance dose
business.industry
Nephrosis, Lipoid
Remission Induction
Glomerulonephritis
General Medicine
Middle Aged
medicine.disease
Treatment Outcome
chemistry
Nephrology
Corticosteroid
Patient Safety
business
Nephrotic syndrome
Immunosuppressive Agents
medicine.drug
Subjects
Details
- ISSN :
- 15333450
- Volume :
- 32
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Journal of the American Society of Nephrology : JASN
- Accession number :
- edsair.doi.dedup.....aa774bf8054aa77ff661c3565820fa92